Page 167 - The Indian Optician Digital Edition Jan-Feb 2020
P. 167

 FIGURE 2 -  LATE
                                                  STAGE FLUORESCEIN
                                                  ANGIOGRAPHY: LEFT
                                                  EYE WITH MACTEL TYPE
                                                  2 SHOWING POOLING
                                                  OF FLUORESCEIN
                                                  WITHIN THE
                                                  TEMPORAL MACULA




                                                        FIGURE 3 -  FUNDUS
                                                          PHOTO: LEFT EYE
                                                   SHOWING TORTUOSITY OF
                                                    VESSELS APPROACHING
                                                    THE FOVEA AND VESSELS
                                                     MAKING A RIGHT TURN
                                                    ESPECIALLY INFERIORLY
                                                    INTO DEEPER LAYERS OF
                                                     THE RETINA (ARROW) 
          MACULAR TELANGIECTASIA
          TYPE 2                              MACULAR

             Macular telangiectasia type      TELANGIECTASIA
          2 (MacTel type 2) is a bilateral    IS A VARIANT
          idiopathic juxtafoveolar            OF COATS
          telangiectasia, commonly referred to
          as perifoveal telangiectasia. It has no   DISEASE THAT
          gender predilection and on average   IS UNILATERAL,
          presents with symptoms in patients   CONGENITAL,
          between the ages of 50 and 60. The   AND NORMALLY
          cause of the disease is unknown and
          is often diagnosed after symptoms   PRESENTS IN
          occur because of the subtle         MIDDLE-AGED
          condition in its earlier stages.    MEN                         FIGURE 4 -  FUNDUS PHOTO: RIGHT EYE SHOWING
                                   1,5
          Gass and Blodi identified 5 stages of                           TORTUOSITY OF VESSELS AND RETINAL PIGMENT
          MacTel type 2. Stage 1 is classified                          DEPOSITION TEMPORALLY IN THE MACULA (ARROW)
          as diffuse hyperflourescence seen in   the disease but some of the most   potentially treatment with anti-VEGF
          the late stage of FA (Figures 1 and 2).   common findings are as follows:   injections if edema and new blood
          The parafoveal area of the retina will   loss of foveal light reflex early in the   vessel growth occurs. Research is
          be less transparent in Stage 2. Stage   condition; loss of retinal transparency   also being done on treatments that
                                                                                                           5,6
          3 is classified by vessels that dilate   described as graying of the retina;   have neuroprotective properties.
          and form a right angle into deeper   crystalline deposits which appear   Outlook for these patients is often
          retinal areas when approaching the   as hyper-reflective dots and can   good as the average acuity for
          fovea (Figure 3). Stage 4 is present   occur at any stage; mild dilation of   patients with MacTel type 2 is
          when pigment clumping occurs due   retinal capillaries often occurring   20/40,  however visual symptoms
          to the leaky telangiectatic vessels   at Stage 3; foveal atrophy that   may be worse than expected due
          (Figure 4). Stage 5 is classified by the   appears as a pseudolamellar macular   to a nasal scotoma. It is rare to see
          formation of vascular membranes   hole (Figure 5); retinal pigment   a patient progress to worse than
          within the macula.                plaques; and telangiectatic vessels   20/200. If acuity levels between
                          1,5
                                            decentered to the temporal macula   20/40 to 20/200 occur, it may be
             Many retinal findings can be   (Figures 6 and 7).  Management of   caused by neovascularization or a
                                                           5
          detected throughout the stages of   the patient includes support and   pseudolamellar hole (Figure 5).


                                                                                 JAN-FEB 2020 | 163 TELANGIECTASIAS






   January-February 2020 SK.indd   76                                                                        02/15/2020   16:09
   162   163   164   165   166   167   168   169   170   171   172